Search

Maryam Monshipouri

Examiner (ID: 849)

Most Active Art Unit
1656
Art Unit(s)
1653, 1652, 1656, 1651
Total Applications
2170
Issued Applications
1561
Pending Applications
225
Abandoned Applications
434

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9589114 [patent_doc_number] => 08778652 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-15 [patent_title] => 'Pentose fermentation by a recombinant microorganism' [patent_app_type] => utility [patent_app_number] => 13/530311 [patent_app_country] => US [patent_app_date] => 2012-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 81345 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13530311 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/530311
Pentose fermentation by a recombinant microorganism Jun 21, 2012 Issued
Array ( [id] => 8542912 [patent_doc_number] => 08318198 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-11-27 [patent_title] => 'Pharmaceutical composition of nanoparticles' [patent_app_type] => utility [patent_app_number] => 13/527886 [patent_app_country] => US [patent_app_date] => 2012-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 26 [patent_no_of_words] => 27190 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13527886 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/527886
Pharmaceutical composition of nanoparticles Jun 19, 2012 Issued
Array ( [id] => 8591923 [patent_doc_number] => 08349799 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-01-08 [patent_title] => 'Pharmaceutical composition of nanoparticles' [patent_app_type] => utility [patent_app_number] => 13/525307 [patent_app_country] => US [patent_app_date] => 2012-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 23 [patent_no_of_words] => 33156 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13525307 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/525307
Pharmaceutical composition of nanoparticles Jun 15, 2012 Issued
Array ( [id] => 9413390 [patent_doc_number] => 08697426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Contaminant control in Zymomonas fermentation using virginiamycin' [patent_app_type] => utility [patent_app_number] => 13/524255 [patent_app_country] => US [patent_app_date] => 2012-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11249 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13524255 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/524255
Contaminant control in Zymomonas fermentation using virginiamycin Jun 14, 2012 Issued
Array ( [id] => 9041691 [patent_doc_number] => 20130244329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'mTOR Ligands and Polynucleotides Encoding mTOR Ligands' [patent_app_type] => utility [patent_app_number] => 13/491315 [patent_app_country] => US [patent_app_date] => 2012-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8592 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13491315 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/491315
mTOR ligands and polynucleotides encoding mTOR ligands Jun 6, 2012 Issued
Array ( [id] => 10339174 [patent_doc_number] => 20150224179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-13 [patent_title] => 'COMPOSITION CAPABLE OF IMPROVING STABILITY OF BACTERIOPHAGE LYSIN PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/404158 [patent_app_country] => US [patent_app_date] => 2012-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3776 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404158 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/404158
Composition capable of improving stability of bacteriophage lysin proteins May 28, 2012 Issued
Array ( [id] => 9970967 [patent_doc_number] => 09017974 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-28 [patent_title] => 'Method for the synthesis of porphyrin-phospholipid conjugates' [patent_app_type] => utility [patent_app_number] => 14/125035 [patent_app_country] => US [patent_app_date] => 2012-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 10 [patent_no_of_words] => 6856 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125035 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/125035
Method for the synthesis of porphyrin-phospholipid conjugates May 24, 2012 Issued
Array ( [id] => 9698984 [patent_doc_number] => 20140248670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'Methods for Enhancing the Degradation of Cellulosic Material with Chitin Binding Proteins' [patent_app_type] => utility [patent_app_number] => 14/117317 [patent_app_country] => US [patent_app_date] => 2012-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39305 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117317 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/117317
Methods for enhancing the degradation of cellulosic material with chitin binding proteins May 17, 2012 Issued
Array ( [id] => 8994782 [patent_doc_number] => 08518667 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'KEX2 cleavage regions of recombinant fusion proteins' [patent_app_type] => utility [patent_app_number] => 13/472296 [patent_app_country] => US [patent_app_date] => 2012-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 17224 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13472296 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/472296
KEX2 cleavage regions of recombinant fusion proteins May 14, 2012 Issued
Array ( [id] => 8359019 [patent_doc_number] => 20120214181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'ASSAY FOR PCSK9 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/466418 [patent_app_country] => US [patent_app_date] => 2012-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12262 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13466418 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/466418
ASSAY FOR PCSK9 INHIBITORS May 7, 2012 Abandoned
Array ( [id] => 8441560 [patent_doc_number] => 20120258176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'NANOPARTICLES FOR PROTEIN DRUG DELIVERY' [patent_app_type] => utility [patent_app_number] => 13/465793 [patent_app_country] => US [patent_app_date] => 2012-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 29840 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13465793 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/465793
Nanoparticles for protein drug delivery May 6, 2012 Issued
Array ( [id] => 8542915 [patent_doc_number] => 08318200 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-11-27 [patent_title] => 'Pharmaceutical composition of nanoparticles' [patent_app_type] => utility [patent_app_number] => 13/462699 [patent_app_country] => US [patent_app_date] => 2012-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 21 [patent_no_of_words] => 24218 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13462699 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/462699
Pharmaceutical composition of nanoparticles May 1, 2012 Issued
Array ( [id] => 9363157 [patent_doc_number] => 20140073030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-13 [patent_title] => 'DETERGENT COMPOSITIONS CONTAINING BACILLUS AGARADHAERENS MANNANASE AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/114709 [patent_app_country] => US [patent_app_date] => 2012-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 31002 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14114709 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/114709
Detergent compositions containing Bacillus agaradhaerens mannanase and methods of use thereof Apr 26, 2012 Issued
Array ( [id] => 10187754 [patent_doc_number] => 09217165 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-22 [patent_title] => 'Mutant strain of lactic acid producing yeast and process for producing lactic acid' [patent_app_type] => utility [patent_app_number] => 14/114001 [patent_app_country] => US [patent_app_date] => 2012-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 6516 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14114001 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/114001
Mutant strain of lactic acid producing yeast and process for producing lactic acid Apr 26, 2012 Issued
Array ( [id] => 8478009 [patent_doc_number] => 20120277417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'ALGAL DESATURASES' [patent_app_type] => utility [patent_app_number] => 13/458914 [patent_app_country] => US [patent_app_date] => 2012-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 2586 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13458914 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/458914
Algal desaturases Apr 26, 2012 Issued
Array ( [id] => 9608000 [patent_doc_number] => 08785165 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-22 [patent_title] => 'Single pH process for starch liquefaction and saccharification for high-density glucose syrups' [patent_app_type] => utility [patent_app_number] => 14/113557 [patent_app_country] => US [patent_app_date] => 2012-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10971 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113557 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/113557
Single pH process for starch liquefaction and saccharification for high-density glucose syrups Apr 26, 2012 Issued
Array ( [id] => 8372779 [patent_doc_number] => 20120222171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'NUCLEOTIDE SEQUENCES AND POLYPEPTIDES ENCODED THEREBY USEFUL FOR MODIFYING PLANT CHARACTERISTICS' [patent_app_type] => utility [patent_app_number] => 13/453954 [patent_app_country] => US [patent_app_date] => 2012-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7287 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13453954 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/453954
NUCLEOTIDE SEQUENCES AND POLYPEPTIDES ENCODED THEREBY USEFUL FOR MODIFYING PLANT CHARACTERISTICS Apr 22, 2012 Abandoned
Array ( [id] => 8328656 [patent_doc_number] => 08236752 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-08-07 [patent_title] => 'Pharmaceutical composition of nanoparticles' [patent_app_type] => utility [patent_app_number] => 13/453149 [patent_app_country] => US [patent_app_date] => 2012-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 20 [patent_no_of_words] => 35594 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13453149 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/453149
Pharmaceutical composition of nanoparticles Apr 22, 2012 Issued
Array ( [id] => 8870733 [patent_doc_number] => 08466110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-18 [patent_title] => 'Use of an agent that restores tissue perfusion and oxygenation' [patent_app_type] => utility [patent_app_number] => 13/449932 [patent_app_country] => US [patent_app_date] => 2012-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 19623 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13449932 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/449932
Use of an agent that restores tissue perfusion and oxygenation Apr 17, 2012 Issued
Array ( [id] => 8328187 [patent_doc_number] => 08236281 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-08-07 [patent_title] => 'Pharmaceutical composition of nanoparticles' [patent_app_type] => utility [patent_app_number] => 13/449157 [patent_app_country] => US [patent_app_date] => 2012-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 20 [patent_no_of_words] => 33662 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13449157 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/449157
Pharmaceutical composition of nanoparticles Apr 16, 2012 Issued
Menu